Deal slippage diagnosis is the systematic analysis of why deals that should close this quarter keep pushing to next quarter—costing you 20-40% of your forecasted revenue. It’s the process of identifying the root causes behind deals that perpetually move from “closing this month” to “probably next month” in your pipeline. Picture this: It’s Friday afternoon.
Your champion can’t sell internally because they lack three critical things: political capital, a business case framework, and the vocabulary to translate your value into their company’s priorities. You’ve invested weeks nurturing this relationship, they’re genuinely excited about your solution, but when they take it to their boss, the deal dies. Picture the scenario: Your